Skip to main content
Livermore
Livermore
ZHEN

CWM, LLC

SEC CIK
0001535847
Latest filing
May 14, 2026

RXRX holding history

Recursion Pharmaceuticals, Inc. in every 13F filed by CWM, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RXRX overviewAll 13F holders of RXRXFull Q1 2026 holdings

Shares (Q1 2026)
21,203
Value
$65.1K
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of RXRX by CWM, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 202621,203$65.1K<0.1%−4,815−18.5%ReducedHolders
Q4 202526,018$106.0K<0.1%+11,413+78.1%AddedHolders
Q3 202514,605$71.0K<0.1%+2,789+23.6%AddedHolders
Q2 202511,816$60.0K<0.1%−12,278−51.0%ReducedHolders
Q1 202524,094$127.0K<0.1%+14,065+140.2%AddedHolders
Q4 202410,029$68.0K<0.1%+2,246+28.9%AddedHolders
Q3 20247,783$51.0K<0.1%+1,538+24.6%AddedHolders
Q2 20246,245$47.0K<0.1%+19+0.3%AddedHolders
Q1 20246,226$62.0K<0.1%00.0%UnchangedHolders
Q4 20236,226$61.0K<0.1%+42+0.7%AddedHolders
Q3 20236,184$47.0K<0.1%00.0%UnchangedHolders
Q2 20236,184$46.0K<0.1%+39+0.6%AddedHolders
Q1 20236,145$41.0K<0.1%+5,836+1,888.7%AddedHolders
Q4 2022309$2.00K<0.1%−8,681−96.6%ReducedHolders
Q3 20228,990$96.0K<0.1%+4,480+99.3%AddedHolders
Q2 20224,510$37.0K<0.1%+4,510NewHolders
Q1 20220$00.0%−4,510−100.0%Sold outHolders
Q4 20214,510$77.0K<0.1%–No prior filingHolders
Q3 2021––––Not filedHolders
Q2 202130$1.00K<0.1%00.0%UnchangedHolders
Q1 202130$1.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.